Aeovian Pharmaceuticals Private
Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway.
Total Funding:
37000000
Investor Type:
Early Stage Venture
Technology:
NeuroTech
Last Funding Type:
Series A
Estimated Revenue:
$1M to $10M
Founded Date:
2012
Industry:
PharmTech
Employee Number:
1-10
Last Funding Date:
2019
Funding Status:
Early Stage Venture
Number Of Exists:
Series A
Headquarters:
San Francisco, California, United States
Investors Number:
4